Myofascial block provides significant pain relief during percutaneous nephrolithotomy

After spinal anaesthesia, opioids and nonsteroidal anti-inflammatory medications (NSAIDS) have long been the mainstays of postoperative pain treatment. However, from the perspective of the patient, their unpleasant side effects, including as gastritis, diarrhoea, nausea, and vomiting, have not proven beneficial. Myofascial blocks, one of the most recent developments in regional anaesthesia, have shown its effectiveness in lowering postoperative site pain without unpleasant side effects, particularly for abdominal and thoracic procedures. The removal of renal and ureteric calculi is accomplished by the minimally invasive procedure known as percutaneous nephrolithotomy (PCNL). Acute pain in the postoperative phase caused by cutaneous innervation at the incision site (T8-T11), renal parenchymal discomfort, and ureteric pain are some of the most frequent consequences of this treatment (T10–L2). Recent research has revealed that erector spinae plane block (ESPB), compared to traditional analgesia with tramadol in PCNL, lowered VAS score, provided acceptable postoperative analgesia, and had comparable haemodynamic alterations and side effects.

Sixty American Society of Anesthesiologists physical status I and II patients scheduled for PCNL under spinal anaesthesia participated in this prospective randomised research. They were randomly divided into two groups of 30 patients each. Following PCNL, group A got ESPB at T8 level along with 20 ml of injection bupivacaine 0.25% and dexamethasone 8 mg, while group B received injection tramadol 1.5 mg/kg intravenously. Visual analogue scale (VAS) score comparison was the main endpoint in the first 24 hours postoperatively, with hemodynamic factors and the need for rescue analgesia as secondary goals. When compared to group B, which had a mean VAS score of 6.61 0.50 at 6 hours, group A (ESPBmean )'s VAS score of 3.15 0.68 was relatively low. After 4 hours postoperatively, VAS scores were still higher, and a significant percentage of group B patients needed rescue analgesics.